{
  "@context": {
    "biotools": "https://bio.tools/ontology/",
    "brick": "https://brickschema.org/schema/Brick#",
    "bsc": "http://bioschemas.org/",
    "bsct": "http://bioschemas.org/types/",
    "csvw": "http://www.w3.org/ns/csvw#",
    "dc": "http://purl.org/dc/elements/1.1/",
    "dcam": "http://purl.org/dc/dcam/",
    "dcat": "http://www.w3.org/ns/dcat#",
    "dcmitype": "http://purl.org/dc/dcmitype/",
    "dct": "http://purl.org/dc/terms/",
    "dcterms": "http://purl.org/dc/terms/",
    "doap": "http://usefulinc.com/ns/doap#",
    "edam": "http://edamontology.org/",
    "foaf": "http://xmlns.com/foaf/0.1/",
    "odrl": "http://www.w3.org/ns/odrl/2/",
    "org": "http://www.w3.org/ns/org#",
    "owl": "http://www.w3.org/2002/07/owl#",
    "prof": "http://www.w3.org/ns/dx/prof/",
    "prov": "http://www.w3.org/ns/prov#",
    "qb": "http://purl.org/linked-data/cube#",
    "rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
    "rdfs": "http://www.w3.org/2000/01/rdf-schema#",
    "sc": "http://schema.org/",
    "schema": "https://schema.org/",
    "sh": "http://www.w3.org/ns/shacl#",
    "skos": "http://www.w3.org/2004/02/skos/core#",
    "sosa": "http://www.w3.org/ns/sosa/",
    "ssn": "http://www.w3.org/ns/ssn/",
    "time": "http://www.w3.org/2006/time#",
    "vann": "http://purl.org/vocab/vann/",
    "void": "http://rdfs.org/ns/void#",
    "xsd": "http://www.w3.org/2001/XMLSchema#"
  },
  "@graph": [
    {
      "@id": "https://bio.tools/SweGen",
      "@type": "sc:SoftwareApplication",
      "dct:conformsTo": "https://bioschemas.org/profiles/ComputationalTool/0.6-DRAFT",
      "sc:applicationSubCategory": [
        {
          "@id": "edam:topic_0749"
        },
        {
          "@id": "edam:topic_3421"
        },
        {
          "@id": "edam:topic_3399"
        }
      ],
      "sc:citation": [
        "pmcid:PMC6143968",
        {
          "@id": "https://doi.org/10.1093/NEUONC/NOY139.194"
        }
      ],
      "sc:description": "P01.152 Evaluation of Factor V Leiden variant as risk a factor for venous thromboembolism in glioblastoma patients | The Swedish Frequency resource for genomics (SweFreq) is a website developed to make genomic datasets more findable and accessible in order to promote collaboration, new research and increase public benefit. You can contact swefreq@scilifelab.se if you want to find out more about this resource and how it could benefit you and your research | {{ mainCtrl.msg.level }}! {{ mainCtrl.msg.msg }}",
      "sc:featureList": [
        {
          "@id": "edam:operation_3196"
        },
        {
          "@id": "edam:operation_3659"
        }
      ],
      "sc:name": "SweGen",
      "sc:url": "https://swegen-exac.nbis.se/"
    },
    {
      "@id": "https://doi.org/10.1093/NEUONC/NOY139.194",
      "@type": "sc:CreativeWork"
    }
  ]
}